Literature DB >> 31350657

Combined Action of GDNF and HGF Up-Regulates Axonal Growth by Increasing ERK1/2 Phosphorylation.

Yu D Molokotina1, М А Boldyreva2,3, I S Stafeev2,3, E V Semina2,3, E K Shevchenko2,3, E S Zubkova2,3, I B Beloglazova2,3, E V Parfenova2,3.   

Abstract

A stimulating effect of a combination of hepatocyte growth factor (HGF) and glial neurotrophic factor (GDNF) on the growth of neurites in the spinal ganglion model was demonstrated. The mechanism of neurite growth in the spinal ganglion model is associated with transactivation of HGF c-met receptor in the presence of both HGF and GDNF. The combination of HGF and GDNF significantly activated mitogenic signaling cascade mediated by protein kinases ERK1/2, which can be a mechanism for increasing the number of neurites. Our findings can be used for developing effective methods for restoring impaired peripheral nerve function after traumatic and ischemic injury using a combination of GDNF and HGF.

Entities:  

Keywords:  glial neurotrophic factor; hepatocyte growth factor; peripheral nerve injury; regeneration

Year:  2019        PMID: 31350657     DOI: 10.1007/s10517-019-04539-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis.

Authors:  Ann Logan; Zsuzsanna Nagy; Nicholas M Barnes; Antonio Belli; Valentina Di Pietro; Barbara Tavazzi; Giuseppe Lazzarino; Giacomo Lazzarino; Lars Bruce; Lennart I Persson
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

2.  The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis.

Authors:  Ann Logan; Antonio Belli; Valentina Di Pietro; Barbara Tavazzi; Giacomo Lazzarino; Renata Mangione; Giuseppe Lazzarino; Inés Morano; Omar Qureshi; Lars Bruce; Nicholas M Barnes; Zsuzsanna Nagy
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.